◆英語タイトル:China Biologic Products Inc (CBPO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C5336
◆発行会社(調査会社):
GlobalData
◆発行日:2018年9月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
China Biologic Products Inc (CBPO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
China Biologic Products Inc (China Biologic) is a biopharmaceutical company that offers plasma collection, research and development, production, commercialization of biopharmaceutical products and development of treatment products. The company manufactures, develops, and markets biologic products for the prevention and treatment of various diseases. Its plasma products include human albumin, human tetanus immunoglobulin, human rabies immunoglobulin, human immunoglobulin for intravenous injection, human hepatitis B immunoglobulin, thymopolypeptides injection, human immunoglobulin, and human coagulation factor VIII. China Biologic’s other product includes placenta polypeptide. The company provides services such as plasma collection, research and development, production, and commercialization of biopharmaceutical products. It offers products to hospitals and other healthcare facilities in China. China Biologic is headquartered in Beijing, China.
China Biologic Products Inc Key Recent Developments
Aug 28,2018: China Biologic responds to lawsuit filed in Cayman Islands by former Chairman
Aug 13,2018: China Biologic names Bing Li as new CEO
Aug 03,2018: China Biologic reports financial results for the second quarter of 2018
May 04,2018: China Biologic Reports Financial Results For First Quarter Of 2018
May 04,2018: China Biologic Announces First Quarter 2018 Financial Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
China Biologic Products Inc – Key Facts 6
China Biologic Products Inc – Key Employees 7
China Biologic Products Inc – Key Employee Biographies 8
China Biologic Products Inc – Major Products and Services 9
China Biologic Products Inc – History 10
China Biologic Products Inc – Company Statement 12
China Biologic Products Inc – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
China Biologic Products Inc – Business Description 16
Product Category: Human albumin 16
Overview 16
Performance 16
Product Category: Immunoglobulin products 16
Overview 16
Performance 16
Product Category: Others 16
Overview 16
Performance 16
Product Category: Placenta polypeptide 17
Overview 17
Performance 17
R&D Overview 17
China Biologic Products Inc – Corporate Strategy 18
China Biologic Products Inc – SWOT Analysis 19
SWOT Analysis – Overview 19
China Biologic Products Inc – Strengths 19
China Biologic Products Inc – Weaknesses 20
China Biologic Products Inc – Opportunities 21
China Biologic Products Inc – Threats 22
China Biologic Products Inc – Key Competitors 23
Section 3 – Company Financial Ratios 24
Financial Ratios – Capital Market Ratios 24
Financial Ratios – Annual Ratios 25
Performance Chart 28
Financial Performance 28
Financial Ratios – Interim Ratios 29
Financial Ratios – Ratio Charts 30
Section 4 – Company’s Lifesciences Financial Deals and Alliances 31
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32
China Biologic Products Inc, Recent Deals Summary 33
Section 5 – Company’s Recent Developments 34
Aug 28, 2018: China Biologic responds to lawsuit filed in Cayman Islands by former Chairman 34
Aug 13, 2018: China Biologic names Bing Li as new CEO 35
Aug 03, 2018: China Biologic reports financial results for the second quarter of 2018 36
May 04, 2018: China Biologic Reports Financial Results For First Quarter Of 2018 42
Feb 28, 2018: China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2017 45
Feb 14, 2018: China Biologic to Build New Collection Station in Hainan Province 49
Feb 14, 2018: China Biologic to Build New Collection Station in Hainan Province 50
Jan 08, 2018: China Biologic Announces Corporate Update 51
Dec 15, 2017: China Biologic Receives Operating Permit for New Collection Facility in Ju County in Shandong Province 52
Nov 01, 2017: China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017 53
Section 6 – Appendix 57
Methodology 57
Ratio Definitions 57
About GlobalData 61
Contact Us 61
Disclaimer 61
List of Tables
China Biologic Products Inc, Key Facts 6
China Biologic Products Inc, Key Employees 7
China Biologic Products Inc, Key Employee Biographies 8
China Biologic Products Inc, Major Products and Services 9
China Biologic Products Inc, History 10
China Biologic Products Inc, Subsidiaries 14
China Biologic Products Inc, Key Competitors 23
China Biologic Products Inc, Ratios based on current share price 24
China Biologic Products Inc, Annual Ratios 25
China Biologic Products Inc, Annual Ratios (Cont...1) 26
China Biologic Products Inc, Annual Ratios (Cont...2) 27
China Biologic Products Inc, Interim Ratios 29
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32
China Biologic Products Inc, Recent Deals Summary 33
Currency Codes 57
Capital Market Ratios 57
Equity Ratios 58
Profitability Ratios 58
Cost Ratios 59
Liquidity Ratios 59
Leverage Ratios 60
Efficiency Ratios 60
List of Figures
China Biologic Products Inc, Performance Chart (2013 - 2017) 28
China Biologic Products Inc, Ratio Charts 30
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 32